| Dr Ronald Scott Sokovich, MD, FACS | |
|
123 Hospital Dr Ste 2006, Watertown, WI 53098-3320 | |
| (920) 261-1334 | |
| (920) 261-8755 |
| Full Name | Dr Ronald Scott Sokovich |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 36 Years |
| Location | 123 Hospital Dr Ste 2006, Watertown, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396796074 | NPI | - | NPPES |
| 31930100 | Medicaid | WI | |
| 553251 | Other | WI | DEAN HEALTH PLAN |
| 1023956 | Other | WI | PHYSCIANS PLUS |
| 340015746 | Other | WI | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 32955-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Watertown Memorial Hospital | Watertown, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watertown Physician Practices Llc | 8022329408 | 53 |
News Archive
CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Police in California have been ordered by a court to return a man's marijuana to him.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
At an event Tuesday, staffers from both sides of the aisle predicted that a "doc fix" agreement would be reached to prevent large scheduled cuts from kicking in.
Shaomei Wang, MD, PhD, a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, received a $4.9 million grant from the California Institute for Regenerative Medicine to advance her work in retinitis pigmentosa, a type of degenerative retinal disease.
› Verified 2 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Police in California have been ordered by a court to return a man's marijuana to him.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
At an event Tuesday, staffers from both sides of the aisle predicted that a "doc fix" agreement would be reached to prevent large scheduled cuts from kicking in.
Shaomei Wang, MD, PhD, a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, received a $4.9 million grant from the California Institute for Regenerative Medicine to advance her work in retinitis pigmentosa, a type of degenerative retinal disease.
› Verified 2 days ago
| Entity Name | Watertown Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770964363 PECOS PAC ID: 8022329408 Enrollment ID: O20150626000114 |
News Archive
CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Police in California have been ordered by a court to return a man's marijuana to him.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
At an event Tuesday, staffers from both sides of the aisle predicted that a "doc fix" agreement would be reached to prevent large scheduled cuts from kicking in.
Shaomei Wang, MD, PhD, a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, received a $4.9 million grant from the California Institute for Regenerative Medicine to advance her work in retinitis pigmentosa, a type of degenerative retinal disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Scott Sokovich, MD, FACS 123 Hospital Dr Ste 2006, Watertown, WI 53098-3320 Ph: (920) 261-1334 | Dr Ronald Scott Sokovich, MD, FACS 123 Hospital Dr Ste 2006, Watertown, WI 53098-3320 Ph: (920) 261-1334 |
News Archive
CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Police in California have been ordered by a court to return a man's marijuana to him.
ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced its new ERT Knowledge Series of educational papers, written by ERT experts. Each paper discusses issues relevant to patient safety in clinical trials today and further establishes ERT as an experienced and reliable partner in products and services for the clinical trials industry.
At an event Tuesday, staffers from both sides of the aisle predicted that a "doc fix" agreement would be reached to prevent large scheduled cuts from kicking in.
Shaomei Wang, MD, PhD, a research scientist in the Eye Program at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, received a $4.9 million grant from the California Institute for Regenerative Medicine to advance her work in retinitis pigmentosa, a type of degenerative retinal disease.
› Verified 2 days ago